Inimex Pharmaceuticals, Inc.
1Patents
1Active
1Granted
38Portfolio score
Filing activity: Oct 4, 2006 → Oct 4, 2006 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8124721B2 | Peptides for modulating innate immunity | Emerging Cross-Sectional Technologies | 2 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.